Markets.com Logo

ICAD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.7283$
  • Previous Close
    3.9085$
  • 52 Week Change
    2.68$
  • Day Range
    -0.18$
  • 52 Week High/Low
    1.335$ - 4.015$
  • Dividend Per Share
    --
  • Market cap
    106 M$
  • EPS
    0
  • Beta
    1.395
  • Volume
    --

About

ICAD.US refers to the stock of iCAD, Inc., a company focused on providing innovative cancer detection and therapy solutions. The company develops advanced image analysis, workflow solutions, and radiation therapy for early detection and treatment of cancer. iCAD's products are designed to improve the accuracy, efficiency, and speed of cancer diagnosis and treatment, ultimately aiming to improve patient outcomes and quality of life. The company's stock is traded on the Nasdaq Stock Market under the symbol ICAD.

AMD's Share Price Surges to Record Highs Driven by Server CPU Momentum

Noah Lee|--

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--
Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Ghko B|--
Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Frances Wang|--
Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Ghko B|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Factors

ICAD.US stock price fluctuates based on several factors: Company Performance: iCAD's financial health, including revenue growth, profitability, and debt levels, significantly impacts investor confidence.

Product Development: Successful development and launch of new cancer detection and therapy solutions drive positive sentiment and increase stock value.

Regulatory Approvals: FDA clearances or approvals for iCAD's products are crucial catalysts that can positively influence the stock price.

Market Conditions: Overall market trends, industry-specific performance of medical device companies, and investor risk appetite affect iCAD's stock.

Competition: The competitive landscape in the cancer detection and therapy market influences iCAD's market share and profitability.

Partnerships & Acquisitions: Strategic alliances, partnerships, or potential acquisition targets can boost investor perception and stock value.

Economic Factors: Broader economic conditions like inflation, interest rates, and economic growth can impact the healthcare sector and iCAD's stock.

News & Events: Company-specific news releases, industry conferences, and major healthcare events can trigger stock price movements.

Analyst Ratings: Recommendations and price targets from financial analysts can influence investor decisions and stock prices.

Investor Sentiment: General investor mood and perception towards iCAD, influenced by social media and online forums, can affect trading activity.

People Also Watch

Latest news

Market and Economic Roundup: Geopolitical Shifts and Financial Performance Insights

Ava Grace|--

SpaceX Accelerates Employee Stock Vesting as IPO Approaches with Record Valuation Target

Sophia Claire|--

Israel-Lebanon Peace Talks: Historic Step Toward De-escalation, Yet Shadowed by Hezbollah's Absence

Sophia Claire|--

Latest Education Articles

How to Trade Natural Gas in 2026

How to Trade Natural Gas in 2026

Julian Parker|--
Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Julian Parker|--
Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Recommended Topics